B
Power Law company profile
Bluebird bio
Biotech & Life Sciences · Cambridge, United States · Founded 1993 · IPO 2013 Thoroughbred
Valuation
$150M
Market cap · 2026
Revenue
$84M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Bluebird bio mafia
Startups founded by Bluebird bio alumni
Former Bluebird bio employees who went on to start their own companies. Sorted by Dealroom signal score.
Kelonia TherapeuticsEst. 2020
Kevin FriedmanUnited StatesSignal score84
ElevateBioEst. 2018
Mitchell H. FinerUnited StatesSignal score66
Generation BioEst. 2016
ASAndy ScharenbergUnited States
Signal score62
Vedere BioEst. 2019
Cyrus MozayeniUnited StatesSignal score60
Chameleon BiosciencesEst. 2017
Genine WinslowUnited StatesSignal score55
Epigene LabsEst. 2019
Akpeli NordorFranceSignal score55
Luna GeneticsEst. 2018
Philip ReillyUnited StatesSignal score42
Global footprint
Where Bluebird bio has talent and traffic
AI talent share
0.6%
of workforce is AI talent
(2 of 323 staff)
(2 of 323 staff)
Core AI10.31%
Other AI10.31%
Non-AI workforce32199.38%
Workforce by country
13
countries with
team presence
team presence
🇺🇸 United States93.5%
🇫🇷 France1.3%
🇿🇦 South Africa0.9%
🇮🇳 India0.9%
🇧🇷 Brazil0.5%
Web traffic by country
1.7K
monthly visits
across markets
across markets
🇺🇸 United States100%
Market sentiment
What the market is saying about Bluebird bio
An AI-synthesized read of the highest-engagement posts about Bluebird bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bluebird bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.